Related by context. All words. (Click for frequent words.) 67 ALLEGRO 61 TMC# C# 57 multicenter phase 56 prospective randomized multicenter 56 Multicenter 55 multicenter randomized placebo controlled 55 Phase IIIb 55 phase IIa 55 GELA 55 double blinded randomized 55 OCCULT 54 AIR2 Trial 54 multicenter prospective 54 EURIDIS 54 multicenter randomized double 54 multicenter Phase II 54 prospective multicenter 54 multicentre 54 double blinded placebo 53 multicenter placebo controlled 53 Phase III randomized 53 Acute Decompensated Heart Failure 53 NO# [002] 53 placebo controlled randomized 53 Phase Ib clinical 53 ECASS 53 multicentre randomized 53 RE LY trial 53 multicentre randomized double 53 phase IIIb 53 randomized multicenter 52 landmark ATHENA 52 Randomised 52 Edge STudy 52 OF DARKNESS 52 phase IIb clinical 52 multicentre study 52 multicenter randomized controlled 51 EINSTEIN DVT 51 randomized Phase III 51 Phase IIIb study 51 substudy 51 placebo controlled Phase III 51 Randomized 51 ILLUSTRATE 51 randomized multicenter trial 51 Trial ASCOT 51 prospective observational 50 PICASSO 50 RE LY 50 Randomized Evaluation 50 SPACE ODYSSEY 50 LEXIVA r 50 phase IIb study 50 subanalysis 50 multicenter randomized 50 placebo controlled clinical 50 CHAMPION PCI 50 multicenter 50 BR.# 50 pegylated liposomal doxorubicin 49 dose escalation Phase 49 TG MV 49 prospective randomized placebo 49 randomized multicentre 49 Phase IIIb clinical 49 TEATRO 49 blind multicenter 49 ritonavir boosted 49 ENDEAVOR 49 TMC# r 49 Laboratorio 49 GISSI 49 multicentre prospective 48 MIST II 48 Proc Am Soc 48 MEND CABG 48 LHRH receptor positive 48 prospective multicenter randomized 48 phase IIb 48 MAXIMA 48 placebo controlled Phase 48 Phase 1b clinical 48 dose escalation clinical 48 ABSORB trial 48 phase Ib 48 Pavia Italy 48 Carotid Revascularization Endarterectomy vs. 48 CYPHER Stent 48 NRTI 48 Clinical Antipsychotic Trials 48 randomized Phase IIb 48 multicenter randomized clinical 48 blind randomized placebo 48 ACCOMPLISH 48 REALISM 48 CUPID 48 efavirenz EFV 47 RE LY ® 47 longitudinal observational study 47 MERLIN TIMI 47 blinded randomized placebo controlled 47 Arimidex Tamoxifen Alone 47 THE FOG 47 ITALIANO 47 Cancer Res 47 prospective nonrandomized 47 elotuzumab 47 CALGB 47 prospective multicentre 47 multicentre phase 47 au coeur 47 relapsed myeloma 47 är ett 47 label multicenter 47 CAMMS# 47 randomized multicenter Phase III 47 EchoCRT 47 WHEL 47 TAPAS 47 AIR CF1 47 doxorubicin docetaxel 47 REVIVE Diabetes 47 doxorubicin cyclophosphamide 46 nonrandomized 46 SORT OUT III 46 placebo controlled 46 PHANTOM OF THE 46 HCV SPRINT 46 multicenter study 46 EXORCIST 46 Phase III randomized controlled 46 antagonist LAMA 46 mcg BID 46 Monitoring ABPM 46 Scandinavian Cardiac Outcomes 46 Intervention Trial 46 Gruppo Italiano 46 dosing cohorts 46 tipranavir r 46 NSABP B 46 recurrent glioblastoma multiforme 46 DAPT 46 multicenter clinical 46 pharmacokinetic PK 46 PRECiSE 46 ascending dose study 46 TAXUS V 46 ROCKET AF 46 prospective randomized controlled 46 TAXUS IV 46 relapsed MM 46 randomized double 46 blinded placebo controlled 46 Phase IIa trial 46 QD dosing 46 Phase 2a trial 45 dose dose escalation 45 Feasibility Trial 45 Ambulatory Blood Pressure 45 inhaled tobramycin 45 onset atrial fibrillation 45 controlled dose escalation 45 PFO migraine 45 lymphoproliferative disorder 45 AIM HIGH 45 Subgroup analysis 45 controlled multicenter 45 oraz 45 liver transplant recipients 45 antiretroviral naïve 45 stage IIIB 45 Parallele 45 BODY SNATCHERS 45 OLYMPIA registry 45 sopra 45 randomized placebo controlled 45 VADT 45 C1INH 45 pT2 45 Randomized controlled 45 GISSI HF 45 i primi 45 randomized Phase 2b 45 phase IIa clinical 45 adjunctive placebo 45 ENDURING 45 PILLAR 45 doi #.# 45 pomalidomide 45 Thrombolysis 45 #mg QD [002] 45 Phase 1b trial 45 HBeAg positive 45 mg BID dose 44 lopinavir r 44 Protelos R 44 dose escalation phase 44 édition du 44 double blind placebo 44 CATIE AD 44 stage IIIb 44 genotype 1a 44 HBeAg negative 44 procainamide 44 randomized crossover 44 dyslipidaemia 44 ascending dose 44 viral kinetic 44 REVIVAL 44 Museo Archeologico 44 Motility 44 melphalan prednisone 44 un nuovo 44 Onc 44 CTEPH 44 Università degli Studi di 44 di un 44 ITALIA 44 nouvel 44 APEX AMI trial 44 einer von 44 recurrent GBM 44 XIENCE V PROMUS Stent 44 Phase 2b study 44 single ascending dose 44 MADRS score 44 blind randomized controlled 44 NATRECOR ® 44 Primary endpoints 44 antiretroviral naive 44 espagnol 44 HPTN 44 atherothrombotic disease 43 RESIST studies 43 morphometric vertebral fractures 43 onderzoek 43 randomized blinded 43 mITT population 43 Zeitschrift für 43 VITAL Trial 43 prospective randomized 43 Centre Hospitalier Universitaire 43 para este 43 Quelques 43 events SAEs 43 rFSH 43 nonmetastatic prostate cancer 43 ORAL 43 CHARIOT 43 treatment naive genotype 43 Phase 2b trial 43 paclitaxel carboplatin 43 Azienda Ospedaliera 43 PreCISe study 43 la forma 43 ABSTRACT 43 del nuevo 43 weekly subcutaneous injections 43 TAXUS Express Stent 43 IV NSCLC 43 EVEREST II 43 Istituto di e 43 Polyp Prevention Trial 43 blind randomized 43 thromboembolic complications 43 RRMS patients 43 SYNTAX 43 Istituto di 43 aantal 43 notizia 43 APTIVUS r 43 más para 43 Flu Cy 43 visceral metastases 43 evaluable subjects 43 prospectively enrolled 43 Sprague Dawley rats 43 HYVET 43 HORIZONS AMI trial 43 europeo 43 SCD HeFT 43 MEND CABG II 43 RE SURGE 43 symptomatic VTE 43 ALL QUIET ON 43 genotypic resistance 43 seguito 43 IDH1 mutation 43 der ersten 42 methylphenidate hydrochloride 42 Phase Ib IIa clinical 42 mildly symptomatic 42 Salvatore Licitra 42 på den 42 uno dei 42 #:#-# [033] 42 des und 42 HIV HCV coinfected 42 progetto 42 FAME Study 42 nulliparous women 42 TEAEs 42 randomized controlled 42 #:# -# [001] 42 MADIT CRT 42 Le roi 42 stage IIIb IV 42 composite endpoint 42 atrioventricular block 42 la sua 42 dosing cohort 42 mg BID 42 Redazioni economiche settore alta 42 clinique 42 SOCCER MOM 42 che ha 42 AIR CF3 42 Screening Trial 42 multiple ascending dose 42 'S NEST 42 Risultati 42 L' Étoile 42 metastatic HRPC 42 HeFT 42 MADIT CRT trial 42 entra 42 darunavir ritonavir 42 Nat Genet 42 trials RCTs 42 Inhalte 42 il suo 42 spazio 42 Museo della 42 LEIA 42 første 42 insieme 42 Heiner Muller 42 irbesartan 42 T1c 42 la versione 42 patientswith 42 zijn er 42 blir 42 null responder 42 il nuovo 42 nucleoside naive 42 longitudinal cohort study 42 XIENCE V demonstrated 42 RSD# oral 42 CC genotype 42 histologically confirmed 42 REYATAZ r arm 42 BWW Interviews 42 mostra 42 placebo controlled dose escalation 42 la lista 42 Wistar rats 42 null responder HCV 41 bacterial prostatitis 41 Acetonide 41 symptomatic BPH 41 TriActiv R 41 suboptimal adherence 41 PARTNER Trial 41 cohort 41 sevelamer carbonate 41 eszopiclone 41 loro 41 MADIT 41 settembre 41 printemps 41 eplerenone 41 undetectable HBV DNA 41 europea 41 Fatebenefratelli 41 mg/m2 cohort 41 THE HOWLING 41 KAPPA 41 CrossRef Medline 41 #mg BID [002] 41 onset diabetes mellitus 41 kuin 41 MADIT II 41 år 41 INSERM U# 41 #mg/m# [001] 41 completely resected 41 luce 41 retrospective cohort 41 DLTs 41 Phase 1b 41 T2 lesions 41 IPAH 41 Nazionale di 41 dan ook 41 digitale 41 från 41 Pressemeldung 41 Nuovi 41 TAXUS VI 41 Shirley Lauro 41 plasma pharmacokinetics 41 oral treprostinil 41 le groupe 41 giorni 41 label dose escalation 41 placebo controlled studies 41 CR CRu 41 IIa trials 41 lingua inglese 41 IRCCS 41 Cosi fan Tutte 41 Dose escalation 41 mcg albinterferon alfa 2b 41 ischemic cardiomyopathy 41 elevated ALT 41 l' Eau 41 Ospedale 41 receiving highly emetogenic 41 sono stati 41 gadolinium enhanced 41 HBeAg negative chronic hepatitis 41 nab paclitaxel 41 ug dose 41 di sviluppo 41 amor y 41 d' autre 41 vicriviroc 41 de l' amour 41 confirmé la clôture du 41 refractory CLL 41 naturelle 41 efficacy endpoint 41 Questi 41 beta blocker therapy 41 neoadjuvant 40 cette nouvelle 40 secondary efficacy endpoint 40 Prostate Lung Colorectal 40 un altro 40 Después 40 fått 40 Università di 40 randomized controlled trial 40 randomized #:#:# 40 randomized controlled clinical 40 SWOG 40 nel corso 40 EMPHASIS HF trial 40 med på 40 samen 40 pharmacokinetics PK 40 Henrik Ibsen Ghosts 40 Mario Negri 40 sont des 40 collaborazione con 40 heavily pretreated 40 dose cohorts 40 entre las 40 colorectal adenoma 40 'S FOLLY 40 RTOG 40 Cohort 40 di Torino 40 tapentadol 40 IL#B 40 Alors que 40 coinfected patients 40 d' amore 40 partenariat 40 disponible en 40 observational cohort study 40 annuncia 40 giugno 40 dose cohort 40 patients evaluable 40 bij de 40 ERSPC 40 ha annunciato oggi 40 nieuw 40 RUPP 40 pheochromocytoma 40 rien de 40 el juego 40 mcg linaclotide 40 myocardial infarctions 40 llamada 40 l' di 40 AVADO 40 ascending doses 40 di cui 40 ADHF 40 retrospective cohort study 40 Confocal 40 receiving VICTRELIS 40 hypercholesterolemic 40 pretransplant 40 Sur le 40 HAMLET 40 euthymic patients 40 nondiabetic patients 40 qu'en 40 realizar 40 findet ihr 40 Cohort Study MACS 40 subgroup analyzes 40 prospective longitudinal 40 medicina 40 spillet 40 fringilla 40 CHAMPION PLATFORM 40 randomized 40 şi de 40 Ovarian PLCO Cancer 40 del suo 40 Laboratorio de 40 locoregional recurrence 40 squamous histology 40 ha annunciato oggi che 40 la prueba 40 Free Survival PFS 40 Les enfants 40 relapsed AML 40 dose escalation trial 40 produzione 40 tra cui 40 Ovarian Cancer Screening 40 niveles de 40 efectos 40 zum Download 40 prospectively randomized 40 experienced virologic failure 40 nieuws 40 noticia 40 TEXAS CHAINSAW 40 ST elevation myocardial 40 Exclusion criteria 40 placebo controlled trials 40 approche 40 hepatitis B vaccine Heplisav 40 ABSSSI 40 paroxysmal AF 40 carboplatin paclitaxel 39 Gaslini 39 alcuni 39 liver histology 39 observational cohort 39 en dehors d' 39 Quando 39 Multicenter AIDS 39 GH deficiency 39 DMARD therapy 39 certolizumab 39 scientifiques 39 traves de 39 rapid virologic response 39 HIV uninfected 39 incluye 39 LEGACY 39 fuori 39 MERITS 39 5-fluorouracil/leucovorin 39 efficacy evaluable 39 Wisconsin Sleep Cohort 39 prospective observational cohort 39 Atherosclerosis MESA 39 insulin detemir 39 de volgende 39 recientemente 39 naar de 39 Partial Nephrectomy 39 COPD exacerbation 39 obra 39 Pharmacological Research 39 risperidone olanzapine 39 randomized clinical 39 Multicenter Automatic Defibrillator Implantation 39 les hommes 39 BARI 2D 39 DOG THE BOUNTY 39 T1DM 39 altri 39 adalimumab 39 cuentas 39 dans tous 39 en cours 39 Museo Civico 39 Anatomie 39 Zolpidem Tartrate 39 everolimus eluting stents 39 ziprasidone 39 barcos 39 Lauri Stallings 39 Así 39 et vous 39 prezzo 39 av som 39 en todos los 39 macroalbuminuria 39 FROM EVIL 39 se le 39 sa première 39 prospective cohort 39 Jeremy Schonfeld 39 du système 39 las versiones 39 verano 39 DMIST 39 nuovo 39 en comparación con 39 le nouveau 39 el nuevo 39 Oncologia 39 Ruxandra Donose 39 giorno 39 le fait 39 lavoro 39 Où 39 potent antiretroviral therapy 39 skal 39 SCIg 39 oltre 39 obtenir 39 prostate carcinoma 39 subtrochanteric 39 versione 39 quello 39 poursuit 39 PLCO 39 prospectively defined 39 che una 39 CR nPR 39 di dollari 39 ricerca 39 mcg doses 39 bientôt 39 Multi Ethnic Study 39 der neuen 39 adjuvant tamoxifen 39 ceux 39 euthyroid 39 accordo 39 dalle 39 permet de 39 anche se 39 en ny 39 è una 39 il prossimo 39 conjugated equine estrogen 39 des choses 39 STEP BD 39 Generic Cialis Soft Tabs 39 genotype 1b 39 plataforma 39 paclitaxel eluting stents 39 fase 39 ENGAGE AF TIMI 39 affective psychosis 39 présenté 39 Là 39 Hospital Universitari 39 low dose cytarabine 39 bedrijf 39 aventure 39 castration resistant prostate cancer 39 comunicato stampa 39 dose escalation study 39 semestre 39 cada uno 39 L' uomo 39 del settore 39 univariate analyzes 38 tutte le 38 sicurezza 38 atheroma volume 38 degli 38 seropositivity 38 ufficiale 38 retrospective observational study 38 HIV seroconversion 38 luglio 38 periprocedural MI 38 virologic response 38 presenta 38 BUMP IN 38 officieel 38 siècle 38 Randomized trials 38 beginnen 38 Reachin 38 pegylated interferon alfa 2b 38 geht es 38 un tema 38 último 38 prossimo 38 vind je 38 totale 38 lancé 38 devrait être 38 Stage IIIb 38 metastatic malignant melanoma 38 à l' origine 38 angiographically 38 il primo 38 secondary endpoint 38 BMI ≥ 38 destino 38 onset AF 38 Mozart Flute Quartet 38 acute leukemias 38 VLBW infants 38 NMIBC 38 BRAIN DAMAGE 38 investigación 38 días 38 asymptomatic metastatic 38 la memoria 38 adenoma recurrence 38 affective disorder 38 cells mcL 38 Sperimentale 38 ha rilasciato 38 série 38 desarrollo de 38 FDA defined valvulopathy 38 det er 38 le texte 38 può 38 Prostate Cancer Prevention 38 à ¨ 38 pareil 38 désormais 38 hemodynamically significant 38 tempo reale 38 sirolimus eluting stents 38 denna 38 saranno 38 del nuovo 38 è il 38 agli 38 sommet 38 adiponectin concentrations 38 con l' 38 Universita 38 elevated serum creatinine 38 di questo 38 normotensive 38 proposé 38 Mae'r heddlu 38 è un 38 kan je 38 il della 38 al mondo 38 dei Tumori 38 Automne 38 previsto 38 på en 38 Programma 38 que ha 38 CD4 + cell 38 sitt 38 un aumento 38 más importante 38 Hacia 38 lacunar 38 kidney allograft 38 imatinib therapy 38 il loro 38 et les autres 38 de référence 38 solifenacin 38 pooled comparator 38 virologic failure 38 enfin 38 dopo 38 sul sito 38 logistic regression analysis 38 histologically proven 38 MIDNIGHT 38 ligula 38 questa 38 som är 38 chemoradiotherapy 38 alemán 38 tasa de 38 alcune 38 hemodialysis patients 38 Moléculaire 38 Si tratta 38 Gloria Patri 38 % CI #.#-#.# [003] 38 constante 38 relapsed GBM 38 noninferiority 38 HSCT 38 CCR5 tropic HIV 38 recurrent endometrial cancer 38 mismos 38 multicenter trials 38 elective percutaneous coronary 38 partir del 38 METHODS 38 baseline LDH 38 prostate cancer PCa 38 evaluable patients 38 underwent resection 38 SIX ROG OTCQX RHHBY 38 las y 37 principali 37 L. acidophilus 37 CARDIA 37 BETTE DAVIS 37 nonfatal myocardial infarction 37 i risultati 37 universitaire 37 atazanavir ritonavir 37 passato 37 systolic dysfunction 37 Rossini Barbiere di Siviglia 37 sul mercato 37 VIRGIL 37 Index CDAI 37 communiqué de presse 37 SENTINEL 37 sono di 37 beschikbaar 37 serum lipid levels 37 voulez 37 è disponibile 37 neun 37 dosage regimens 37 su en 37 har en 37 HIV seronegative 37 Birth Cohort 37 depuis le 37 operable pancreatic cancer 37 Voor meer informatie 37 ECOG 37 tutta 37 meta regression 37 dose regimens 37 à #h# 37 underwent CABG 37 UKPDS 37 placebo controlled clinical trials 37 homocysteine concentrations 37 la nuova 37 PROM NIGHT 37 multivariable Cox 37 di della 37 pharmacodynamics PD 37 ALLHAT 37 hanno 37 de uma 37 la venta 37 altre 37 nonfatal MI 37 beauté 37 rispetto 37 premier trimestre 37 Donizetti Lucia 37 retrospective observational 37 mondiale 37 graft dysfunction 37 che le 37 conferenza 37 joka 37 mà 37 disponibile 37 ed è 37 una delle 37 cytogenetic response 37 dicembre 37 cynnwys 37 originale 37 tirofiban 37 alle di 37 entre los 37 plasma folate 37 een te 37 Swedish Mammography Cohort 37 virologic response EVR 37 DCCT 37 superiore 37 elevated troponin 37 che la 37 ha annunciato 37 antibody titer 37 presso 37 nous les 37 supporto 37 meilleur 37 om det 37 stesso 37 HAPPILY AFTER 37 annuncia la 37 ului 37 evaluable 37 slechts 37 le monde 37 está el 37 prostate cancer CaP 37 om een 37 FORTIS M trial 37 % CI #.#-#.# [007] 37 restrizioni 37 hacia la 37 presión 37 % Confidence Interval 37 RCTs 37 COU AA 37 prospectively evaluated 37 Shyam Bajaj 37 blind placebo controlled 37 TIMI 37 inhaled corticosteroid therapy 37 mg/m2 dose 37 máquina 37 fost 37 Fratres 37 di aver 37 dysglycemia 37 lys 37 meta analysis 37 URTI 37 GastroPlus TM 37 breast carcinoma 37 Violon 37 cuales 37 Adam Hougland 37 diferencia 37 peptic ulcer bleeding 37 très bien 37 T2DM 37 på och 37 éditions 37 STUMBLING 37 kunst 37 de novo AML 37 dispositif 37 ovariectomized 37 metastatic RCC 37 è di 37 stelle 37 ci après 37 che il 37 Osteoporotic Fractures 37 Pour une 37 serum IGF 37 ENCORE 37 voor een 37 di questa 37 efecto 36 plus tôt 36 rendu 36 underwent liver transplantation 36 lamivudine refractory patients 36 multivariate Cox 36 Russian composer Pyotr 36 che l' 36 thyroidectomy 36 Mahler Rückert Lieder 36 acid suppressive medications 36 recién 36 Questo 36 prodotti 36 maggio 36 Bagets 36 de van het 36 è l' 36 Associazione Italiana 36 STUFF HAPPENS 36 pour la recherche 36 multivariate analyzes 36 il proprio 36 città 36 relapsing remitting 36 verum 36 contiene 36 post hoc 36 sulla 36 Istituto 36 Univariate analysis 36 veel 36 la propria 36 doet 36 Kaplan Meier analysis 36 MY SUPER 36 EMPHASIS HF 36 COLORADO SCHOOL 36 Nana Visitor 36 zwar 36 definite stent thrombosis 36 clinicopathological 36 pharmacodynamic effects 36 KRAS mutations occur 36 fino al